(a) Giornal, F.; Pazenok, S.; Rodefeld, L.; Lui, N.; Vors, J.-P.; Leroux, F. R. J. Fluorine Chem. 2013, 152, 2. (b) Lamberth, C. Heterocycles 2007, 71, 1467.
[2]
Raju, H.; Chandrappa, S.; Prasanna, D. S.; Ananda, H.; Nagamani, T. S.; Byregowda, S. M.; Rangappa, K. S. Recent Pat. Anti-Cancer Drug Discovery 2011, 6, 186.
[3]
Bekhit, A. A.; Hymete, A.; Bekhit, A. E. A.; Damtew, A.; Aboul-Enein, H. Y. Mini-Rev. Med. Chem. 2010, 10, 1014.
Wang, J.; Li, P.-F.; Chan, S. H.; Chan, A. S. C.; Kwong, F. Y. Tetrahedron Lett. 2012, 53, 2887.
[14]
Wu, Y.-J. Tetrahedron Lett. 2006, 47, 8459.
[15]
Uddin, M. I.; Nakano, K.; Ichikawa, Y.; Kotsuki, H. Synlett 2008, 1402.
[16]
Lee, I. Y. C.; Lee, K. C.; Lee, H. W. Bull. Korean Chem. Soc. 2012, 33, 3535.
[17]
Bhanuchandra, M.; Kuram, M. R.; Sahoo, A. K. Org. Biomol. Chem. 2012, 10, 3538.
[18]
During preparation of this manuscript, an organocatalytic asymmetric aza-Michael addition of pyrazole to chalcone was developed. See: Li, P.; Fang, F.; Chen, J.; Wang, J. Tetrahedron: Asymmetry 2014, 25, 98.
[19]
(a) Lehmann, F. Synlett 2004, 2447. (b) Duan, X.-F.; Zhang, Z.-B. Chin. J. Org. Chem. 2006, 26, 573 (in Chinese). (段新方, 张站斌, 有机化学, 2006, 26, 573.)
[20]
(a) Liu, D.; Gao, W.; Wang, C.; Zhang, X. Angew. Chem., Int. Ed. 2005, 44, 1687. (b) Calow, A. D. J.; Batsanov, A. S.; Fernández, E.; Solé, C.; Whiting, A. Chem. Commun. 2012, 48, 11401.
[21]
Wu, Y.; Wang, J.; Li, P.; Kwong, F. Y. Synlett 2012, 788.
[22]
(a) Kawatsura, M.; Aburatani, S.; Uenishi, J. Tetrahedron 2007, 63, 4172. (b) Aburatani, S.; Kawatsura, M.; Uenishi, J. Heterocycles 2007, 71, 189.